Amgen, Inc - Reimagining immunotherapy in mAPMR prostate cancer: Current evidence and future opportunities for T-cell engaging strategies

Name: Amgen, Inc - Reimagining immunotherapy in mAPMR prostate cancer: Current evidence and future opportunities for T-cell engaging strategies
Start: 2026-12-04T12:30
End: 2026-12-04T14:00
Location: Suntec Convention Centre

ESMO Asia 2026 · 4 December 2026 · 12:30–14:00 · Hall 406

Amgen, Inc - Reimagining immunotherapy in mAPMR prostate cancer: Current evidence and future opportunities for T-cell engaging strategies was a session at ESMO Asia 2026 on 4 December 2026 in Singapore, with 4 speakers on record.

Speakers

Ben Tran — Chair Peter MacCallum Cancer Centre
Nobuaki Matsubara — Speaker National Cancer Center Hospital East
Lisa G. Horvath — Speaker Chris O'Brien Lifehouse
Ravindran Kanesvaran — Speaker NCCS - National Cancer Centre Singapore